V591
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for V591, covering 2021-12-23 to 2021-12-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) [Phase 1, Phase 2]